BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis, and biological activities of new thieno[3,2-d] pyrimidines as selective type 4 phosphodiesterase inhibitors. 1998

M I Crespo, and L Pagès, and A Vega, and V Segarra, and M López, and T Doménech, and M Miralpeix, and J Beleta, and H Ryder, and J M Palacios
Almirall Prodesfarma S.A., Research Center, Cardener 68-74, 08024 Barcelona, Spain.

A common pharmacophore for compounds structurally related to nitraquazone has been derived. Using this pharmacophore, new structures have been designed, synthesized, and evaluated for their inhibitory potencies against cyclic adenosine 5'-monophosphate (cAMP) specific phosphodiesterase (PDE 4). From these compounds, 4-benzylamino-2-butylthieno[3,2-d]pyrimidine (4) was selected for optimization. The effects of changes to the lipophilic groups and the amino linkage on the PDE 4 activity have been investigated. As a result, some potent PDE 4 inhibitors, selective with respect to PDE 3, have been identified. A selected group of compounds have been further evaluated for their ability to displace [3H]rolipram from its binding site and also to potentiate isoprenaline-induced cAMP accumulation in isolated guinea pig eosinophils. Of these, 2-butyl-4-cyclohexylaminothieno[3,2-d]pyrimidine (33) has an interesting profile, with an important improvement in PDE 4/[3H]rolipram ratio with respect to reference drugs, and good activity in cAMP potentiation, consistent with efficient cell penetration.

UI MeSH Term Description Entries
D008297 Male Males
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010726 Phosphodiesterase Inhibitors Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. Phosphodiesterase Antagonists,Phosphodiesterase Inhibitor,Phosphoric Diester Hydrolase Inhibitors,Antiphosphodiesterases,Inhibitor, Phosphodiesterase
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D011760 Pyrrolidinones A group of compounds that are derivatives of oxo-pyrrolidines. A member of this group is 2-oxo pyrrolidine, which is an intermediate in the manufacture of polyvinylpyrrolidone. (From Merck Index, 11th ed) Pyrrolidinone,Pyrrolidone,Pyrrolidones
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004804 Eosinophils Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin. Eosinophil
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic

Related Publications

M I Crespo, and L Pagès, and A Vega, and V Segarra, and M López, and T Doménech, and M Miralpeix, and J Beleta, and H Ryder, and J M Palacios
Synthesis and biological activity of pyrido[3',2':4,5]thieno[3,2-d]pyrimidines as phosphodiesterase type 4 inhibitors.
October 2010, Journal of medicinal chemistry,
M I Crespo, and L Pagès, and A Vega, and V Segarra, and M López, and T Doménech, and M Miralpeix, and J Beleta, and H Ryder, and J M Palacios
Synthesis and anticancer activities of thieno[3,2-d]pyrimidines as novel HDAC inhibitors.
January 2014, Bioorganic & medicinal chemistry,
M I Crespo, and L Pagès, and A Vega, and V Segarra, and M López, and T Doménech, and M Miralpeix, and J Beleta, and H Ryder, and J M Palacios
3D-QSAR studies on thieno[3,2-d]pyrimidines as phosphodiesterase IV inhibitors.
April 2003, Bioorganic & medicinal chemistry letters,
M I Crespo, and L Pagès, and A Vega, and V Segarra, and M López, and T Doménech, and M Miralpeix, and J Beleta, and H Ryder, and J M Palacios
Design, Synthesis and Biological Evaluation of Novel Urea and Thiourea Bearing thieno[3,2-d]-pyrimidines as PI3 Kinase Inhibitors.
January 2018, Anti-cancer agents in medicinal chemistry,
M I Crespo, and L Pagès, and A Vega, and V Segarra, and M López, and T Doménech, and M Miralpeix, and J Beleta, and H Ryder, and J M Palacios
Synthesis and biological evaluation of thieno[3,2-d]- pyrimidinones, thieno[3,2-d]pyrimidines and quinazolinones: conformationally restricted 17b-hydroxysteroid dehydrogenase type 2 (17b-HSD2) inhibitors.
April 2013, Molecules (Basel, Switzerland),
M I Crespo, and L Pagès, and A Vega, and V Segarra, and M López, and T Doménech, and M Miralpeix, and J Beleta, and H Ryder, and J M Palacios
Antiproliferative activities of halogenated thieno[3,2-d]pyrimidines.
April 2014, Bioorganic & medicinal chemistry,
M I Crespo, and L Pagès, and A Vega, and V Segarra, and M López, and T Doménech, and M Miralpeix, and J Beleta, and H Ryder, and J M Palacios
Simple approach to thieno[3,2-d]pyrimidines as new scaffolds of antimicrobial activities.
September 2016, Acta pharmaceutica (Zagreb, Croatia),
M I Crespo, and L Pagès, and A Vega, and V Segarra, and M López, and T Doménech, and M Miralpeix, and J Beleta, and H Ryder, and J M Palacios
Synthesis and biological evaluation of new benzo-thieno[3,2-d]pyrimidin-4-one sulphonamide thio-derivatives as potential selective cyclooxygenase-2 inhibitors.
August 2013, Molecular diversity,
M I Crespo, and L Pagès, and A Vega, and V Segarra, and M López, and T Doménech, and M Miralpeix, and J Beleta, and H Ryder, and J M Palacios
Design, synthesis, and biological evaluation of new phosphodiesterase type 4 inhibitors.
October 2004, Bioorganic & medicinal chemistry,
M I Crespo, and L Pagès, and A Vega, and V Segarra, and M López, and T Doménech, and M Miralpeix, and J Beleta, and H Ryder, and J M Palacios
Design, Synthesis and Biological Evaluation of New Thieno[2,3- d]pyrimidines as Anti-inflammatory Agents.
January 2015, Anti-inflammatory & anti-allergy agents in medicinal chemistry,
Copied contents to your clipboard!